Cytokines and Perinatal Brain Damage

Clinics in Perinatology

Volumn 35, Issue 4, 2008, Pages 643-663

  Dammann, Olaf ^a   O'Shea, T Michael ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral palsy; Chorioamnionitis; Cytokines; Developmental disability; Mental retardation; Periventricular leukomalacia

Indexed keywords

CHEMOKINE; CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; NEU DIFFERENTIATION FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

BRAIN DAMAGE; CELL ACTIVATION; ENCEPHALITIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INFECTION; LEUKOCYTE MIGRATION; MICROGLIA; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PERINATAL MORBIDITY; PRIORITY JOURNAL; REVIEW; UPREGULATION;

BRAIN; BRAIN INJURIES; CYTOKINES; FETUS; HUMANS; INFANT, NEWBORN; INFECTION; INFLAMMATION MEDIATORS;

EID: 56049091743     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2008.07.011     Document Type: Review

References (189)

1. Honeycutt A., Dunlap L., Chen H., et al. Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment-United States, 2003. MMWR Morb Mortal Wkly Rep 53 3 (2004) 57-59
2. Jarbrink K., and Knapp M. The economic impact of autism in Britain. Autism 5 1 (2001) 7-22
3. Dammann O., and Leviton A. Brain damage in preterm newborns: might enhancement of developmentally-regulated endogenous protection open a door for prevention?. Pediatrics 104 (1999) 541-550
4. Dammann O., Cesario A., and Hallen M. NEOBRAIN-an EU-funded project committed to protect the newborn brain. Neonatology 92 4 (2007) 217-218
5. Wolfberg A.J., Dammann O., and Gressens P. Anti-inflammatory and immunomodulatory strategies to protect the perinatal brain. Semin Fetal Neonatal Med 12 4 (2007) 296-302
6. Leviton A., Gilles F., Neff R., et al. Multivariate analysis of risk of perinatal telencephalic leukoencephalopathy. Am J Epidemiol 104 (1976) 621-626
7. Gilles F.H., Leviton A., and Kerr C.S. Endotoxin leukoencephalopathy in the telencephalon of the newborn kitten. J Neurol Sci 27 (1976) 183-191
8. Gilles F.H., Averill D.R., and Kerr C.S. Neonatal endotoxin encephalopathy. Ann Neurol 2 1 (1977) 49-56
9. Ornoy A., and Altshuler G. Maternal endotoxemia, fetal anomalies, and central nervous-system damage-rat model of a human problem. Am J Obstet Gynecol 124 2 (1976) 196-204
10. Nelson K.B., and Ellenberg J.H. Predictors of low and very low birth-weight and the relation of these to cerebral-palsy. JAMA 254 11 (1985) 1473-1479
11. Leviton A., and Gilles F.H. Acquired perinatal leukoencephalopathy. Ann Neurol 16 1 (1984) 1-8
12. Wu Y.W. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev 8 1 (2002) 25-29
13. Wang X.Y., Rousset C.I., Hagberg H., et al. Lipopolysaccharide-induced inflammation and perinatal brain injury. Semin Fetal Neonatal Med 11 5 (2006) 343-353
14. Dammann O., and Leviton A. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. Semin Pediatr Neurol 5 (1998) 190-201
15. Hagberg H., and Mallard C. Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol 18 2 (2005) 117-123
16. Dammann O., and Leviton A. Inflammatory brain damage in preterm newborns-dry numbers, wet lab, and causal inferences. Early Hum Dev 79 1 (2004) 1-15
17. Silverstein F.S., Barks J.D., Hagan P., et al. Cytokines and perinatal brain injury. Neurochem Int 30 4-5 (1997) 375-383
18. Dammann O., and Leviton A. Intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 42 1 (1997) 1-8
19. Wu Y.W., and Colford J.M. Chorioamnionitis as a risk factor for cerebral palsy-a meta-analysis. JAMA 284 11 (2000) 1417-1424
20. Wu Y.W., Escobar G.J., Grether J.K., et al. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 290 20 (2003) 2677-2684
21. Badawi N., Felix J.F., Kurinczuk J.J., et al. Cerebral palsy following term newborn encephalopathy: a population-based study. Dev Med Child Neurol 47 5 (2005) 293-298
22. Badawi N., Kurinczuk J.J., Keogh J.M., et al. Intrapartum risk factors for newborn encephalopathy: the Western Australian case-control study. Br Med J 317 7172 (1998) 1554-1558
23. Blume H.K., Li C.I., Loch C.M., et al. Intrapartum fever and chorioamnionitis as risks for encephalopathy in term newborns: a case-control study. Dev Med Child Neurol 50 1 (2008) 19-24
24. Holzman C., Lin X.M., Senagore P., et al. Histologic chorioamnionitis and preterm delivery. Am J Epidemiol 166 7 (2007) 786-794
25. Romero R., Gomez R., Chaiworapongsa T., et al. The role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol 15 (2001) 41-56
26. Leviton A. Preterm birth and cerebral-palsy-is tumor-necrosis-factor the missing link. Dev Med Child Neurol 35 6 (1993) 553-556
27. Adinolfi M. Infectious-diseases in pregnancy, cytokines and neurological impairment-an hypothesis. Dev Med Child Neurol 35 6 (1993) 549-553
28. Stoll B.J., Hansen N.I., Adams-Chapman I., et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 292 19 (2004) 2357-2365
29. Toti P., De Felice C., Palmeri M.L., et al. Inflammatory pathogenesis of cortical polymicrogyria: an autopsy study. Pediatr Res 44 3 (1998) 291-296
30. Brown A.S., and Susser E.S. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev 8 1 (2002) 51-57
31. Dammann O., Drescher J., and Veelken N. Maternal fever at birth and non-verbal intelligence at age 9 years in preterm infants. Dev Med Child Neurol 45 3 (2003) 148-151
32. Gabay C., and Kushner I. Mechanisms of disease-acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
33. Hagberg H., Peebles D., and Mallard C. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 8 1 (2002) 30-38
34. Hagberg H., Dammann O., Mallard C., et al. Preconditioning and the developing brain. Semin Perinatol 28 6 (2004) 389-395
35. Mallard C., and Hagberg H. Inflammation-induced preconditioning in the immature brain. Semin Fetal Neonatal Med 12 4 (2007) 280-286
36. Megyeri P., Abraham C.S., Temesvari P., et al. Recombinant human tumor-necrosis-factor-alpha constricts pial arterioles and increases blood-brain-barrier permeability in newborn piglets. Neurosci Lett 148 1-2 (1992) 137-140
37. Dammann O., and Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 42 (1997) 1-8
38. Dammann O., and Leviton A. The role of the fetus in perinatal infection and neonatal brain injury. Curr Opin Pediatr 12 (2000) 99-104
39. Patrick L.A., and Smith G.N. Proinflammatory cytokines: a link between chorioamnionitis and fetal brain injury. J Obstet Gynaecol Can 24 9 (2002) 705-709
40. Cornette L. Fetal and neonatal inflammatory response and adverse outcome. Semin Fetal Neonatal Med 9 6 (2004) 459-470
41. Edwards A.D., and Tan S. Perinatal infections, prematurity and brain injury. Curr Opin Pediatr 18 2 (2006) 119-124
42. Back S.A. Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Ment Retard Dev Disabil Res Rev 12 2 (2006) 129-140
43. Adams-Chapman I. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 19 3 (2006) 290-297
44. Murthy V., and Kennea N.L. Antenatal infection/inflammation and fetal tissue injury. Best Pract Res Clin Obstet Gynaecol 21 3 (2007) 479-489
45. Khwaja O., and Volpe J.J. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 93 2 (2008) F152-F161
46. Romero R., Espinoza J., Goncalves L.F., et al. The role of inflammation and infection in preterm birth. Semin Reprod Med 25 1 (2007) 21-39
47. Felderhoff-Mueser U., Schmidt O.I., Oberholzer A., et al. IL-18: a key player in neuroinflammation and neurodegeneration?. Trends Neurosci 28 9 (2005) 487-493
48. MartinAncel A., GarciaAlix A., PascualSalcedo D., et al. Interleukin-6 in the cerebrospinal fluid after perinatal asphyxia is related to early and late neurological manifestations. Pediatrics 100 5 (1997) 789-794
49. Nelson K.B., Dambrosia J.M., Grether J.K., et al. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 44 (1998) 665-675
50. Grether J.K., Nelson K.B., Dambrosia J.M., et al. Interferons and cerebral palsy. J Pediatr 134 3 (1999) 324-332
51. Oygur N., Sonmez O., Saka O., et al. Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-alpha and interleukin-1 beta concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy. Arch Dis Child 79 3 (1998) F190-F193
52. Shalak L.F., Laptook A.R., Jafri H.S., et al. Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants. Pediatrics 110 4 (2002) 673-680
53. Silveira R.C., and Procianoy R.S. Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr 143 5 (2003) 625-629
54. Aly H., Khashaba M.T., El Ayouty M., et al. IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev 28 3 (2006) 178-182
55. Yoon B.H., Romero R., and Yang S.H. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 174 (1996) 1433-1440
56. Yoon B.H., Jun J.K., Romero R., et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 177 1 (1997) 19-26
57. Yoon B.H., Romero R., Kim C.J., et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 177 2 (1997) 406-411
58. Duggan P.J., Maalouf E.F., Watts T.L., et al. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 358 9294 (2001) 1699-1700
59. Yanowitz T.D., Jordan J.A., Gilmour C.H., et al. Hemodynamic disturbances in premature infants born after chorioamnionitis: association with cord blood cytokine concentrations. Pediatr Res 51 3 (2002) 310-316
60. Minagawa K., Tsuji Y., Ueda H., et al. Possible correlation between high levels of IL-18 in the cord blood of pre-term infants and neonatal development of periventricular leukomalacia and cerebral palsy. Cytokine 17 3 (2002) 164-170
61. Nelson K.B., Grether J.K., Dambrosia J.M., et al. Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res 53 4 (2003) 600-607
62. Heep A., Behrendt D., Nitsch P., et al. Increased serum levels of interleukin 6 are associated with severe intraventricular haemorrhage in extremely premature infants. Arch Dis Child 88 6 (2003) F501-F504
63. Viscardi R.M., Muhumuza C.K., Rodriguez A., et al. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 55 6 (2004) 1009-1017
64. Hansen-Pupp I., Harling S., Berg A.C., et al. Circulating interferon-gamma and white matter brain damage in preterm infants. Pediatr Res 58 5 (2005) 946-952
65. Kaukola T., Satyaraj E., Patel D.D., et al. Cerebral palsy is characterized by protein mediators in cord serum. Ann Neurol 55 2 (2004) 186-194
66. Harding D., Dhamrait S., Millar A., et al. Is interleukin-6-174 genotype associated with the development of septicemia in preterm infants?. Pediatrics 112 4 (2003) 800-803
67. Harding D., Brull D., Humphries S.E., et al. Variation in the interleukin-6 gene is associated with impaired cognitive development in children born prematurely: a preliminary study. Pediatr Res 58 1 (2005) 117-120
68. Heep A., Schueller A.C., Kattner E., et al. Association of two tumour necrosis factor gene polymorphisms with the incidence of severe intraventricular haemorrhage in preterm infants. J Med Genet 42 7 (2005) 604-608
69. Dammann O., Durum S.K., and Leviton A. Modification of the infection-associated risks of preterm birth and white matter damage in the preterm newborn by polymorphisms in the tumor necrosis factor-locus?. Pathogenesis 2 (1998) 1-7
70. Cai Z.W., Pang Y., Lin S.Y., et al. Differential roles of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res 975 1-2 (2003) 37-47
71. Opal S.M., and Depalo V.A. Anti-inflammatory cytokines. Chest 117 4 (2000) 1162-1172
72. Kremlev S.G., and Palmer C. Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. J Neuroimmunol 162 1-2 (2005) 71-80
73. Rodts-Palenik S., Wyatt-Ashmead J., Pang Y., et al. Maternal infection-induced white matter injury is reduced by treatment with interleukin-10. Am J Obstet Gynecol 191 4 (2004) 1387-1392
74. Mesples B., Plaisant F., and Gressens P. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Brain Res Dev Brain Res 141 1-2 (2003) 25-32
75. Dordelmann M., Kerk J., Dressler F., et al. Interleukin-10 high producer allele and ultrasound-defined periventricular white matter abnormalities in preterm infants: a preliminary study. Neuropediatrics 37 3 (2006) 130-136
76. Cherian S., Thoresen M., Silver I.A., et al. Transforming growth factor-beta s in a rat model of neonatal posthaemorrhagic hydrocephalus. Neuropathol Appl Neurobiol 30 6 (2004) 585-600
77. Heep A., Stoffel-Wagner B., Bartmann P., et al. Vascular endothelial growth factor and transforming growth factor-beta 1 are highly expressed in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus. Pediatr Res 56 5 (2004) 768-774
78. Lin C.H., Cheng F.C., Lu Y.Z., et al. Protection of ischemic brain cells is dependent on astrocyte-derived growth factors and their receptors. Exp Neurol 201 1 (2006) 225-233
79. Basu A., Krady J.K., Enterline J.R., et al. Transforming growth factor beta 1 prevents IL-1 beta-induced microglial activation, whereas TNF alpha- and IL-6-stimulated activation are not antagonized. Glia 40 1 (2002) 109-120
80. Mesples B., Fontaine R.H., Lelievre V., et al. Neuronal TGF-beta(1) mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice. Neurobiol Dis 18 1 (2005) 193-205
81. Guan J., Miller O.T., Waugh K.M., et al. TGF beta-I and neurological function after hypoxia-ischemia in adult rats. Neuroreport 15 6 (2004) 961-964
82. Charo I.F., and Ransohoff R.M. Mechanisms of disease-the many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354 6 (2006) 610-621
83. Savarin-Vuaillat C., and Ransohof R.M. Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?. Neurotherapeutics 4 4 (2007) 590-601
84. Ubogu E.E., Cossoy M.B., and Ransohoff R.M. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci 27 1 (2006) 48-55
85. Bacon K., Baggiolini M., Broxmeyer H., et al. Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22 10 (2002) 1067-1068
86. Ng P.C., and Lam H.S. Diagnostic markers for neonatal sepsis. Curr Opin Pediatr 18 2 (2006) 125-131
87. Bartha A.I., Foster-Barber A., Miller S.P., et al. Neonatal encephalopathy: association of cytokines with MR spectroscopy and outcome. Pediatr Res 56 6 (2004) 960-966
88. Ellison V.J., Mocatta T.J., Winterbourn C.C., et al. The relationship of CSF and plasma cytokine levels to cerebral white matter injury in the premature newborn. Pediatr Res 57 2 (2005) 282-286
89. Ehrlich L.C., Hu S.X., Sheng W.S., et al. Cytokine regulation of human microglial cell IL-8 production. J Immunol 160 4 (1998) 1944-1948
90. Chew L.J., Takanohashi A., and Bell M. Microglia and inflammation: impact on developmental brain injuries. Ment Retard Dev Disabil Res Rev 12 2 (2006) 105-112
91. Bona E., Andersson A.L., Blomgren K., et al. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res 45 4 (1999) 500-509
92. Thibeault I., Laflamme N., and Rivest S. Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP-1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines. J Comp Neurol 434 4 (2001) 461-477
93. Dammann O., Durum S., and Leviton A. Do white cells matter in white matter damage?. Trends Neurosci 24 6 (2001) 320-324
94. Leviton A., Dammann O., and Durum S.K. The adaptive immune response in neonatal cerebral white matter damage. Ann Neurol 58 6 (2005) 821-828
95. Curatolo L., Valsasina B., Caccia C., et al. Recombinant human IL-2 is cytotoxic to oligodendrocytes after in vitro self aggregation. Cytokine 9 10 (1997) 734-739
96. Kadhim H., Tabarki B., De Prez C., et al. Interleukin-2 in the pathogenesis of perinatal white matter damage. Neurology 58 7 (2002) 1125-1128
97. Sun F.Y., and Guo X. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J Neurosci Res 79 1-2 (2005) 180-184
98. Kaur C., Sivakumar V., Ang L.S., et al. Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity. J Neurochem 98 4 (2006) 1200-1216
99. Laudenbach V., Fontaine R.H., Medja F., et al. Neonatal hypoxic preconditioning involves vascular endothelial growth factor. Neurobiol Dis 26 1 (2007) 243-252
100. Hansen-Pupp I., Hellstrom-Westas L., Cilio C.M., et al. Inflammation at birth and the insulin-like growth factor system in very preterm infants. Acta Paediatr 96 6 (2007) 830-836
101. Wood T.L., Loladze V., Altieri S., et al. Delayed IGF-1 administration rescues oligodendrocyte progenitors from glutamate-induced cell death and hypoxic-ischemic brain damage. Dev Neurosci 29 4-5 (2007) 302-310
102. Guan J., Bennet L., George S., et al. Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep. J Cereb Blood Flow Metab 21 5 (2001) 493-502
103. Brywe K.G., Mallard C., Gustavsson M., et al. IGF-I neuroprotection in the immature brain after hypoxia-ischemia, involvement of Akt and GSK3 beta?. Eur J Neurosci 21 6 (2005) 1489-1502
104. Dammann O., Bueter W., Leviton A., et al. Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage. Neonatology 93 3 (2008) 182-187
105. Bernstein H.G., Lendeckel U., Bertram I., et al. Localization of neuregulin-1 alpha (heregulin-alpha) and one of its receptors, ErbB-4 tyrosine kinase, in developing and adult human brain. Brain Res Bull 69 5 (2006) 546-559
106. Vartanian T., Fischbach G., and Miller R. Failure of spinal cord oligodendrocyte development in mice lacking neuregulin. Proc Natl Acad Sci U S A 96 2 (1999) 731-735
107. Xu Z.F., Jiang J., Ford G., et al. Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke. Biochem Biophys Res Commun 322 2 (2004) 440-446
108. Xu Z.F., Croslan D.R., Harris A.E., et al. Extended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic stroke. J Cereb Blood Flow Metab 26 4 (2006) 527-535
109. Xu Z.F., Ford G.D., Croslan D.R., et al. Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression. Neurobiol Dis 19 3 (2005) 461-470
110. Li Y.G., Xu Z.F., Ford G.D., et al. Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia. Brain Res 1184 (2007) 277-283
111. Corfas G., Roy K., and Buxbaum J. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 7 6 (2004) 575-580
112. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 32 2 (2006) 200-202
113. Dammann O., and Leviton A. Perinatal brain damage causation. Dev Neurosci 29 4-5 (2007) 280-288
114. Welin A.K., Svedin P., Lapatto R., et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res 61 2 (2007) 153-158
115. Svedin P., Guan J., Mathai S., et al. Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat. Dev Neurosci 29 4-5 (2007) 393-402
116. Lyng K., Munkeby B.H., Saugstad O.D., et al. Effect of interleukin-10 on newborn piglet brain following hypoxia-ischemia and endotoxin-induced inflammation. Biol Neonate 87 3 (2005) 207-216
117. Cai Z.W., Lin S.Y., Pang Y., et al. Brain injury induced by intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in the neonatal rat. Pediatr Res 56 3 (2004) 377-384
118. Jurewicz A., Matysiak M., Tybor K., et al. Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor. Brain 128 (2005) 2675-2688
119. Pang Y., Cai Z.W., and Rhodes P.G. Effect of tumor necrosis factor-alpha on developing optic nerve oligodendrocytes in culture. J Neurosci Res 80 2 (2005) 226-234
120. Cammer W., and Zhang H. Maturation of oligodendrocytes is more sensitive to TNF alpha than is survival of precursors and immature oligodendrocytes. J Neuroimmunol 97 1-2 (1999) 37-42
121. Wang X.Y., Hagberg H., Zhu C.L., et al. Effects of intrauterine inflammation on the developing mouse brain. Brain Res 1144 (2007) 180-185
122. Inder T.E., Wells S.J., Mogridge N.B., et al. Defining the nature of the cerebral abnormalities in the premature infant: a qualitative magnetic resonance imaging study. J Pediatr 143 2 (2003) 171-179
123. Cai Z.W., Pan Z.L., Pang Y., et al. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 47 1 (2000) 64-72
124. Rousset C.I., Chalon S., Cantagrel S., et al. Maternal exposure to LPS induces hypomyelination in the internal capsule and programmed cell death in the deep gray matter in newborn rats. Pediatr Res 59 3 (2006) 428-433
125. Urakubo A., Jarskog L.F., Lieberman J.A., et al. Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr Res 47 1 (2001) 27-36
126. Ling Z.D., Gayle D.A., Ma S.Y., et al. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord 17 1 (2002) 116-124
127. Bell M.J., and Hallenbeck J.M. Effects of intrauterine inflammation on developing rat brain. J Neurosci Res 70 4 (2002) 570-579
128. Gilmore J.H., Jarskog L.F., and Vadlamudi S. Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the rat. J Neuroimmunol 138 1-2 (2003) 49-55
129. Duncan J.R., Cock M.L., Scheerlinck J.P., et al. White matter injury after repeated endotoxin exposure in the preterm ovine fetus. Pediatr Res 52 6 (2002) 941-949
130. Debillon T., Gras-Leguen C., Verielle V., et al. Intrauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr Res 47 6 (2000) 736-742
131. Debillon T., Gras-Leguen C., Leroy S., et al. Patterns of cerebral inflammatory response in a rabbit model of intrauterine infection-mediated brain lesion. Brain Res Dev Brain Res 145 1 (2003) 39-48
132. Harnett E.L., Dickinson M.A., and Smith G.N. Dose-dependent lipopolysaccharide-induced fetal brain injury in the guinea pig. Am J Obstet Gynecol 197 2 (2007) e1-e7
133. Liverman C.S., Kaftan H.A., Cui L., et al. Altered expression of pro-inflammatory and developmental genes in the fetal brain in a mouse model of maternal infection. Neurosci Lett 399 3 (2006) 220-225
134. Golan H.M., Lev V., Hallak M., et al. Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology 48 6 (2005) 903-917
135. Hava G., Vered L., Yael M., et al. Alternations in behaviour in adults offspring mice following maternal inflammation during pregnancy. Dev Psychobiol 48 2 (2006) 162-168
136. Paintlia M.K., Paintlia A.S., Contreras M.A., et al. Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: attenuation by N-acetyl cysteine. Exp Neurol 210 (2008) 560-576
137. Lante F., Meunier J., Guiramand J., et al. Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain. Free Radic Biol Med 42 8 (2007) 1231-1245
138. Lante F., Meunier J., Guiramand J., et al. Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation. Hippocampus 18 6 (2008) 602-609
139. Lasala N., and Zhou H.P. Effects of maternal exposure to LPS on the inflammatory response in the offspring. J Neuroimmunol 189 1-2 (2007) 95-101
140. Pang Y., Cai Z.W., and Rhodes P.G. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res Dev Brain Res 140 2 (2003) 205-214
141. Lehnardt S., Lachance C., Patrizi S., et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22 7 (2002) 2478-2486
142. Lehnardt S., Massillon L., Follett P., et al. Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 100 14 (2003) 8514-8519
143. Lehnardt S., Schott E., Trimbuch T., et al. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci 28 10 (2008) 2320-2331
144. Fan L.W., Pang Y., Lin S., et al. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience 133 1 (2005) 159-168
145. Cai Z., Lin S., Fan L.W., et al. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience 137 2 (2006) 425-435
146. Stolp H.B., Dziegielewska K.M., Ek C.J., et al. Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat. Eur J Neurosci 22 11 (2005) 2805-2816
147. Stolp H.B., Ek C.J., Johansson P.A., et al. Effect of minocycline on inflammation-induced damage to the blood-brain barrier and white matter during development. Eur J Neurosci 26 12 (2007) 3465-3474
148. Yan E.W., Castillo-Melendez M., Nicholls T., et al. Cerebrovascular responses in the fetal sheep brain to low-dose endotoxin. Pediatr Res 55 5 (2004) 855-863
149. Dammann O. Persistent neuro-inflammation in cerebral palsy: a therapeutic window of opportunity?. Acta Paediatr 96 1 (2007) 6-7
150. Hohlfeld R., Kerschensteiner M., and Meinl E. Dual role of inflammation in CNS disease. Neurology 68 (2007) S58-S63
151. Crutcher K.A., Gendelman H.E., Kipnis J., et al. Debate: "is increasing neuroinflammation beneficial for neural repair?". J Neuroimmune Pharmacol 1 3 (2006) 195-211
152. Krumbholz M., Theil D., Derfuss T., et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 201 2 (2005) 195-200
153. Bruce A.J., Boling W., Kindy M.S., et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2 7 (1996) 788-794
154. Saha R.N., Liu A., and Pahan K. Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine. J Neuroimmune Pharmacol 1 2 (2006) 212-222
155. Moalem G., Leibowitz-Amit R., Yoles E., et al. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5 1 (1999) 49-55
156. Schwartz M., Butovsky O., Bruck W., et al. Microglial phenotype: is the commitment reversible?. Trends Neurosci 29 2 (2006) 68-74
157. Banati R.B., and Graeber M.B. Surveillance. Intervention and cytotoxicity-is there a protective role of microglia. Dev Neurosci 16 3-4 (1994) 114-127
158. Schwartz M., and Kipnis J. Therapeutic T cell-based vaccination for neurodegenerative disorders-the role of CD4(+) CD25(+) regulatory T cells. Ann NY Acad Sci 1051 (2005) 701-708
159. Ziv Y., and Schwartz M. Immune-based regulation of adult neurogenesis: implications for learning and memory. Brain Behav Immun 22 2 (2008) 167-176
160. Ziv Y., Ron N., Butovsky O., et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 9 2 (2006) 268-275
161. Medzhitov R., and Janeway C. Innate immune recognition: mechanisms and pathways. Immunol Rev 173 (2000) 89-97
162. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7 5 (2007) 379-390
163. De Dooy J., Colpaert C., Schuerwegh A., et al. Relationship between histologic chorioamnionitis and early inflammatory variables in blood, tracheal aspirates, and endotracheal colonization in preterm infants. Pediatr Res 54 1 (2003) 113-119
164. Kashlan F., Smulian J., Shen-Schwarz S., et al. Umbilical vein interleukin 6 and tumor necrosis factor alpha plasma concentrations in the very preterm infant. Pediatr Infect Dis J 19 3 (2000) 238-243
165. Kaukola T., Herva R., Perhomaa M., et al. Population cohort associating chorioamnionitis, cord inflammatory cytokines and neurologic outcome in very preterm, extremely low birth weight infants. Pediatr Res 59 3 (2006) 478-483
166. Martin H., Olander B., and Norman M. Reactive hyperemia and interleukin 6, interleukin 8, and tumor necrosis factor-alpha in the diagnosis of early-onset neonatal sepsis. Pediatrics 108 4 (2001) E61
167. Ng P.C., Li K., Chui K.M., et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res 61 1 (2007) 93-98
168. Ng P.C., Li K., Wong R.P., et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child 88 3 (2003) 209-213
169. Franz A.R., Bauer K., Schalk A., et al. Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicenter, randomized, controlled trial. Pediatrics 114 1 (2004) 1-8
170. Verboon-Maciolek M.A., Thijsen S.F., Hemels M.A., et al. Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatr Res 59 3 (2006) 457-461
171. Edelson M.B., Bagwell C.E., and Rozycki H.J. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 103 4 (1999) 766-771
172. Goldenberg R.L., Andrews W.W., Goepfert A.R., et al. The Alabama preterm birth study: umbilical cord blood Ureaplasma urealyticum and mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol 198 1 (2008) e1-e5
173. Whitaker A.H., Feldman J.F., VanRossem R., et al. Neonatal cranial ultrasound abnormalities in low birth weight infants: relation to cognitive outcomes at six years of age. Pediatrics 98 4 (1996) 719-729
174. Munshi U.K., Niu J.O., Siddiq M.M., et al. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 24 5 (1997) 331-336
175. Murch S.H., Costeloe K., Klein N.J., et al. Early production of macrophage inflammatory protein-1 alpha occurs in respiratory distress syndrome and is associated with poor outcome. Pediatr Res 40 3 (1996) 490-497
176. Jonsson B., Tullus K., Brauner A., et al. Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child 77 3 (1997) F198-F201
177. Turunen R., Nupponen I., Siitonen S., et al. Onset of mechanical ventilation is associated with rapid activation of circulating phagocytes in preterm infants. Pediatrics 117 2 (2006) 448-454
178. Kuebler W.M., Ying X.Y., Singh B., et al. Pressure is proinflammatory in lung venular capillaries. J Clin Invest 104 4 (1999) 495-502
179. Baier R.J. Genetics of perinatal brain injury in the preterm infant. Front Biosci 11 (2006) 1371-1387
180. Mcguire W., Hill A.V., Allsopp C.E., et al. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371 6497 (1994) 508-511
181. Aidoo M., Mcelroy P.D., Kolczak M.S., et al. Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asenibo Bay Cohort project IX. Genet Epidemiol 21 3 (2001) 201-211
182. Papile L.A., Munsickbruno G., and Schaefer A. Relationship of cerebral intraventricular hemorrhage and early-childhood neurologic handicaps. J Pediatr 103 2 (1983) 273-277
183. Adcock K., Hedberg C., Loggins J., et al. MCP-1-2518 and TGF-beta(1) +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun 4 6 (2003) 420-426
184. Nelson K.B., Dambrosia J.M., Iovannisci D.M., et al. Genetic polymorphisms and cerebral palsy in very preterm infants. Pediatr Res 57 4 (2005) 494-499
185. Gibson C.S., MacLennan A.H., Goldwater P.N., et al. The association between inherited cytokine polymorphisms and cerebral palsy. Am J Obstet Gynecol 194 3 (2006) 674-680
186. Harding D.R., Dhamrait S., Whitelaw A., et al. Does interleukin-6 genotype influence cerebral injury or developmental progress after preterm birth?. Pediatrics 114 4 (2004) 941-947
187. Gaynor J.W., Gerdes M., Zackai E.H., et al. Apolipoprotein E genotype and neurodevelopmental sequelae of infant cardiac surgery. J Thorac Cardiovasc Surg 126 6 (2003) 1736-1745
188. Wright R.O., Hu H., Silverman E.K., et al. Apolipoprotein E genotype predicts 24-month Bayley Scales Infant Development score. Pediatr Res 54 6 (2003) 819-825
189. Yanamandra K., Boggs P., Loggins J., et al. Interleukin-10-1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. Pediatr Pulmonol 39 5 (2005) 426-432